{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,31]],"date-time":"2025-10-31T21:51:06Z","timestamp":1761947466768},"reference-count":40,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2008,1,1]],"date-time":"2008-01-01T00:00:00Z","timestamp":1199145600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Neurosurgery Clinics of North America"],"published-print":{"date-parts":[[2008,1]]},"DOI":"10.1016\/j.nec.2007.09.001","type":"journal-article","created":{"date-parts":[[2007,12,26]],"date-time":"2007-12-26T11:24:39Z","timestamp":1198668279000},"page":"31-40","source":"Crossref","is-referenced-by-count":17,"title":["Multiple Myeloma: Primary Bone Tumor with Systemic Manifestations"],"prefix":"10.1016","volume":"19","author":[{"given":"Mark H.","family":"Bilsky","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Syed","family":"Azeem","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.nec.2007.09.001_bib1","doi-asserted-by":"crossref","first-page":"10","DOI":"10.3322\/canjclin.55.1.10","article-title":"Cancer statistics, 2005","volume":"55","author":"Jemal","year":"2005","journal-title":"CA Cancer J Clin"},{"issue":"1","key":"10.1016\/j.nec.2007.09.001_bib2","first-page":"29","article-title":"Multiple myeloma: review of 869 cases","volume":"50","author":"Kyle","year":"1975","journal-title":"Mayo Clin Proc"},{"issue":"6","key":"10.1016\/j.nec.2007.09.001_bib3","doi-asserted-by":"crossref","first-page":"664","DOI":"10.1634\/theoncologist.12-6-664","article-title":"New drugs for myeloma","volume":"12","author":"Richardson","year":"2007","journal-title":"Oncologist"},{"key":"10.1016\/j.nec.2007.09.001_bib4","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1056\/NEJM199607113350204","article-title":"A prospective randomized trial of autologous bone marrow transplantation and chemotherapy in multiple myeloma. Intergroup Francais du Myelome","volume":"335","author":"Attai","year":"1996","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.nec.2007.09.001_bib5","doi-asserted-by":"crossref","first-page":"1875","DOI":"10.1056\/NEJMoa022340","article-title":"High-dose chemotherapy with hematopoietic stem-cell rescue for multiple myeloma","volume":"348","author":"Child","year":"2003","journal-title":"N Engl J Med"},{"issue":"5","key":"10.1016\/j.nec.2007.09.001_bib6","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1053\/bbmt.2001.v7.pm11400947","article-title":"Bone density loss after allogeneic hematopoietic stem cell transplantation: a prospective study","volume":"7","author":"Stern","year":"2001","journal-title":"Biol Blood Marrow Transplant"},{"issue":"5","key":"10.1016\/j.nec.2007.09.001_bib7","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1080\/02841860701233435","article-title":"The use of bisphosphonates in cancer patients","volume":"46","author":"Wu","year":"2007","journal-title":"Acta Oncol"},{"issue":"2","key":"10.1016\/j.nec.2007.09.001_bib8","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1006\/bbrc.1998.9788","article-title":"RANK is the essential signaling receptor for osteoclast differentiation factor in osteoclastogenesis","volume":"253","author":"Nakagawa","year":"1998","journal-title":"Biochem Biophys Res Commun"},{"issue":"2","key":"10.1016\/j.nec.2007.09.001_bib9","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1016\/S0092-8674(00)80209-3","article-title":"Osteoprotegerin: a novel secreted protein involved in the regulation of bone density","volume":"89","author":"Simonet","year":"1997","journal-title":"Cell"},{"issue":"6717","key":"10.1016\/j.nec.2007.09.001_bib10","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1038\/16852","article-title":"OPGL is a key regulator of osteoclastogenesis, lymphocyte development and lymph-node organogenesis","volume":"397","author":"Kong","year":"1999","journal-title":"Nature"},{"issue":"18","key":"10.1016\/j.nec.2007.09.001_bib11","doi-asserted-by":"crossref","first-page":"2412","DOI":"10.1101\/gad.13.18.2412","article-title":"RANK is essential for osteoclast and lymph node development","volume":"13","author":"Dougall","year":"1999","journal-title":"Genes Dev"},{"issue":"20","key":"10.1016\/j.nec.2007.09.001_bib12","doi-asserted-by":"crossref","first-page":"11581","DOI":"10.1073\/pnas.201394498","article-title":"Multiple myeloma disrupts the TRANCE\/osteoprotegerin cytokine axis to trigger bone destruction and promote tumor progression","volume":"98","author":"Pearse","year":"2001","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"13","key":"10.1016\/j.nec.2007.09.001_bib13","doi-asserted-by":"crossref","first-page":"3527","DOI":"10.1182\/blood.V98.13.3527","article-title":"Myeloma cells induce imbalance in the osteoprotegerin\/osteoprotegerin ligand system in the human bone marrow environment","volume":"98","author":"Giuliani","year":"2001","journal-title":"Blood"},{"issue":"6","key":"10.1016\/j.nec.2007.09.001_bib14","doi-asserted-by":"crossref","first-page":"2094","DOI":"10.1182\/blood-2002-09-2684","article-title":"RANK ligand and osteoprotegerin in myeloma bone disease","volume":"101","author":"Sezer","year":"2003","journal-title":"Blood"},{"issue":"20","key":"10.1016\/j.nec.2007.09.001_bib15","doi-asserted-by":"crossref","first-page":"1513","DOI":"10.1056\/NEJMoa013444","article-title":"High bone density due to a mutation in LDL-receptor-related protein 5","volume":"346","author":"Boyden","year":"2002","journal-title":"N Engl J Med"},{"issue":"3","key":"10.1016\/j.nec.2007.09.001_bib16","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1016\/S1534-5807(01)00041-7","article-title":"Dickkopf1 is required for embryonic head induction and limb morphogenesis in the mouse","volume":"1","author":"Mukhopadhyay","year":"2001","journal-title":"Dev Cell"},{"issue":"5","key":"10.1016\/j.nec.2007.09.001_bib17","doi-asserted-by":"crossref","first-page":"966","DOI":"10.1093\/emboj\/21.5.966","article-title":"The Wnt antagonist Dickkopf-1 is regulated by Bmp signaling and c-Jun and modulates programmed cell death","volume":"21","author":"Grotewold","year":"2002","journal-title":"EMBO J"},{"issue":"26","key":"10.1016\/j.nec.2007.09.001_bib18","doi-asserted-by":"crossref","first-page":"2483","DOI":"10.1056\/NEJMoa030847","article-title":"The role of the Wnt-signaling antagonist DKK1 in the development of osteolytic lesions in multiple myeloma","volume":"349","author":"Tian","year":"2003","journal-title":"N Engl J Med"},{"issue":"1","key":"10.1016\/j.nec.2007.09.001_bib19","doi-asserted-by":"crossref","first-page":"50","DOI":"10.3324\/haematol.10554","article-title":"A prospective comparison of 18F-fluorodeoxyglucose positron emission tomography-computed tomography, magnetic resonance imaging and whole-body planar radiographs in the assessment of bone disease in newly diagnosed multiple myeloma","volume":"92","author":"Zamagni","year":"2007","journal-title":"Haematologica"},{"key":"10.1016\/j.nec.2007.09.001_bib20","doi-asserted-by":"crossref","DOI":"10.1007\/s00256-007-0323-5","article-title":"Whole-body imaging of the musculoskeletal system: the value of MR imaging","author":"Schmidt","year":"2007","journal-title":"Skeletal Radiol"},{"issue":"3","key":"10.1016\/j.nec.2007.09.001_bib21","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1016\/j.ejso.2005.09.018","article-title":"Whole body MR imaging: applications in oncology","volume":"32","author":"Johnston","year":"2006","journal-title":"Eur J Surg Oncol"},{"issue":"3","key":"10.1016\/j.nec.2007.09.001_bib22","doi-asserted-by":"crossref","first-page":"342","DOI":"10.1097\/01.rct.0000237820.41549.c9","article-title":"Efficacy of multidetector row computed tomography of the spine in patients with multiple myeloma: comparison with magnetic resonance imaging and fluorodeoxyglucose-positron emission tomography","volume":"31","author":"Hur","year":"2007","journal-title":"J Comput Assist Tomogr"},{"issue":"9","key":"10.1016\/j.nec.2007.09.001_bib23","doi-asserted-by":"crossref","first-page":"632","DOI":"10.1007\/s00256-006-0127-z","article-title":"Comparison of imaging with FDG PET\/CT with other imaging modalities in myeloma","volume":"35","author":"Breyer","year":"2006","journal-title":"Skeletal Radiol"},{"issue":"5","key":"10.1016\/j.nec.2007.09.001_bib24","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1007\/s00259-005-0004-3","article-title":"Role of 18F-FDG PET\/CT in the assessment of bone involvement in newly diagnosed multiple myeloma: preliminary results","volume":"33","author":"Nanni","year":"2006","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"10.1016\/j.nec.2007.09.001_bib25","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1186\/1477-7819-5-68","article-title":"11C-choline vs. 18F-FDG PET\/CT in assessing bone involvement in patients with multiple myeloma","volume":"5","author":"Nanni","year":"2007","journal-title":"World J Surg Oncol"},{"issue":"1","key":"10.1016\/j.nec.2007.09.001_bib26","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1358\/dot.2004.40.1.799436","article-title":"Bisphosphonate treatment for multiple myeloma","volume":"40","author":"Terpos","year":"2004","journal-title":"Drugs Today"},{"issue":"2","key":"10.1016\/j.nec.2007.09.001_bib27","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1200\/JCO.1998.16.2.593","article-title":"Long-term pamidronate treatment of advanced multiple myeloma patients reduces skeletal events. Myeloma Aredia Study Group","volume":"16","author":"Berenson","year":"1998","journal-title":"J Clin Oncol"},{"issue":"5","key":"10.1016\/j.nec.2007.09.001_bib28","first-page":"377","article-title":"Zoledronic acid versus pamidronate in the treatment of skeletal metastases in patients with breast cancer or osteolytic lesions of multiple myeloma: a phase III, double-blind, comparative trial","volume":"7","author":"Rosen","year":"2001","journal-title":"Cancer J"},{"issue":"2","key":"10.1016\/j.nec.2007.09.001_bib29","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1046\/j.1365-2141.1998.00567.x","article-title":"A randomized trial of the effect of clodronate on skeletal morbidity in multiple myeloma. MRC Working Party on Leukaemia in Adults","volume":"100","author":"McCloskey","year":"1998","journal-title":"Br J Haematol"},{"issue":"4","key":"10.1016\/j.nec.2007.09.001_bib30","doi-asserted-by":"crossref","first-page":"1035","DOI":"10.1046\/j.1365-2141.2001.02851.x","article-title":"Long-term follow-up of a prospective, double-blind, placebo-controlled randomized trial of clodronate in multiple myeloma","volume":"113","author":"McCloskey","year":"2001","journal-title":"Br J Haematol"},{"issue":"17","key":"10.1016\/j.nec.2007.09.001_bib31","doi-asserted-by":"crossref","first-page":"2464","DOI":"10.1200\/JCO.2007.12.1269","article-title":"American Society of Clinical Oncology 2007 clinical practice guideline update on the role of bisphosphonates in multiple myeloma","volume":"25","author":"Kyle","year":"2007","journal-title":"J Clin Oncol"},{"issue":"6","key":"10.1016\/j.nec.2007.09.001_bib32","doi-asserted-by":"crossref","first-page":"620","DOI":"10.1111\/j.1365-2141.2006.06230.x","article-title":"Incidence, risk factors and management of osteonecrosis of the jaw in patients with multiple myeloma: a single-centre experience in 303 patients","volume":"134","author":"Zervas","year":"2006","journal-title":"Br J Haematol"},{"issue":"6","key":"10.1016\/j.nec.2007.09.001_bib33","doi-asserted-by":"crossref","first-page":"1307","DOI":"10.1016\/j.hoc.2006.09.009","article-title":"Surgical approach to epidural spinal cord compression","volume":"20","author":"Bilsky","year":"2006","journal-title":"Hematol Oncol Clin North Am"},{"issue":"2","key":"10.1016\/j.nec.2007.09.001_bib34","doi-asserted-by":"crossref","first-page":"140","DOI":"10.3171\/spi.2006.5.2.140","article-title":"Multiple myeloma of the cervical spine: treatment strategies for pain and spinal instability","volume":"5","author":"Rao","year":"2006","journal-title":"J Neurosurg Spine"},{"issue":"9486","key":"10.1016\/j.nec.2007.09.001_bib35","doi-asserted-by":"crossref","first-page":"643","DOI":"10.1016\/S0140-6736(05)66954-1","article-title":"Direct decompressive surgical resection in the treatment of spinal cord compression caused by metastatic cancer: a randomised trial","volume":"366","author":"Patchell","year":"2005","journal-title":"Lancet"},{"issue":"24","key":"10.1016\/j.nec.2007.09.001_bib36","doi-asserted-by":"crossref","first-page":"E925","DOI":"10.1097\/01.brs.0000245923.66285.71","article-title":"Transoral vertebroplasty for renal cell metastasis involving the axis: case report","volume":"31","author":"Sachs","year":"2006","journal-title":"Spine"},{"issue":"9","key":"10.1016\/j.nec.2007.09.001_bib37","doi-asserted-by":"crossref","first-page":"2382","DOI":"10.1200\/JCO.2002.09.097","article-title":"Kyphoplasty in the treatment of osteolytic vertebral compression fractures as a result of multiple myeloma","volume":"20","author":"Dudeney","year":"2002","journal-title":"J Clin Oncol"},{"issue":"2","key":"10.1016\/j.nec.2007.09.001_bib38","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1148\/radiology.200.2.8685351","article-title":"Percutaneous vertebroplasty for osteolytic metastases and myeloma: effects of the percentage of lesion filling and the leakage of methyl methacrylate at clinical follow-up","volume":"200","author":"Cotten","year":"1996","journal-title":"Radiology"},{"issue":"4","key":"10.1016\/j.nec.2007.09.001_bib39","doi-asserted-by":"crossref","first-page":"436","DOI":"10.3171\/spi.2005.2.4.0436","article-title":"Percutaneous vertebroplasty and kyphoplasty performed at a cancer center: refuting proposed contraindications","volume":"2","author":"Hentschel","year":"2005","journal-title":"J Neurosurg Spine"},{"issue":"2","key":"10.1016\/j.nec.2007.09.001_bib40","doi-asserted-by":"crossref","first-page":"168","DOI":"10.3171\/spi.2006.5.2.168","article-title":"Percutaneous vertebroplasty of a myelomatous compression fracture in the presence of previous posterior instrumentation. Report of two cases","volume":"5","author":"Chakrabarti","year":"2006","journal-title":"J Neurosurg Spine"}],"container-title":["Neurosurgery Clinics of North America"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S104236800700085X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S104236800700085X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,5,6]],"date-time":"2019-05-06T03:11:26Z","timestamp":1557112286000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S104236800700085X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2008,1]]},"references-count":40,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2008,1]]}},"alternative-id":["S104236800700085X"],"URL":"https:\/\/doi.org\/10.1016\/j.nec.2007.09.001","relation":{},"ISSN":["1042-3680"],"issn-type":[{"value":"1042-3680","type":"print"}],"subject":[],"published":{"date-parts":[[2008,1]]}}}